Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.
Yonemori K, Tamura K, Kodaira M, Fujikawa K, Sagawa T, Esaki T, Shirakawa T, Hirai F, Yokoi Y, Kawata T, Hatano B, Takahashi Y.
Yonemori K, et al. Among authors: kodaira m.
Cancer Chemother Pharmacol. 2016 Sep;78(3):525-31. doi: 10.1007/s00280-016-3106-7. Epub 2016 Jul 15.
Cancer Chemother Pharmacol. 2016.
PMID: 27422301
Free PMC article.
Clinical Trial.